Article Publication Charges
EFORT Open Reviews offers a waiver on all article publication charges (APCs) for authors associated with EFORT: no APCs will be payable by members of EFORT participating national associations.
For authors who are not members of an EFORT participating association, an APC of €1000 will be payable for each accepted paper from 1 January 2017.
We recognise that some authors do not have access to funding to cover publication costs. EFORT Open Reviews offers a 100% waiver to corresponding authors from institutions based in Hinari Group A countries, and a 50% waiver to authors from institutions based in Hinari Group B countries.
Article Submission Charges
EFORT Open Reviews does not charge for article submission.
Open Access and Licensing
All published articles are made freely and permanently available online without subscription charges. Articles are published under a Creative Commons Attribution Non-Commercial licence (CC-BY-NC), allowing others to read, download, copy, distribute, print, search, or link to the full texts of articles without permission providing the work is properly referenced and the re-use is non-commercial. Authors retain the copyright of their work but agree to license their work according to the Creative Commons Attribution-Non-Commercial License 4.0.
The full terms of the CC BY-NC licence are incorporated below and may also be accessed here: http://creativecommons.org/licenses/by-nc/4.0/legalcode
If your funder requires you to publish under a different type of licence please email: email@example.com.
EFORT Open Reviews confirms compliance with the UK Wellcome Trust’s revised requirements, including publication under a CC-BY licence. The publishers confirm that they will refund Author Publication Charges to the Wellcome Trust for any article where they fail to comply with these requirements, unless the failure to comply is caused by circumstances outside the control of the publishers.
All articles are archived in Portico and LOCKSS (deposit pending), ensuring that the materials remain accessible to future researchers.